CONMED CORPORATION CONMED Corporation Share Price
Equities
CNMD
US2074101013
Medical Equipment, Supplies & Distribution
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 65.78 USD | +6.27% |
|
-9.44% | -39.93% |
| Sales 2024 * | 1.34B 107B | Sales 2025 * | 1.45B 116B | Capitalization | 2.03B 162B |
|---|---|---|---|---|---|
| Net income 2024 * | 110M 8.78B | Net income 2025 * | 147M 11.74B | EV / Sales 2024 * | 2.14 x |
| Net Debt 2024 * | 841M 67.14B | Net Debt 2025 * | 772M 61.64B | EV / Sales 2025 * | 1.93 x |
| P/E ratio 2024 * |
18.6
x | P/E ratio 2025 * |
14.1
x | Employees | 4,000 |
| Yield 2024 * |
1.22% | Yield 2025 * |
1.22% | Free-Float | 97.73% |
More Fundamentals
* Assessed data
More news
Latest transcript on CONMED Corporation
More recommendations
More press releases
| 1 day | +6.27% | ||
| 1 week | -9.44% | ||
| Current month | -17.86% | ||
| 1 month | -17.86% | ||
| 3 months | -28.53% | ||
| 6 months | -30.73% | ||
| Current year | -39.93% |
1 week
61.05
73.26
1 month
61.0580.65
Current year
61.05113.68
1 year
61.05138.47
3 years
61.05159.11
5 years
37.66159.11
10 years
35.51159.11
| Managers | Title | Age | Since |
|---|---|---|---|
Curt Hartman
CEO | Chief Executive Officer | 60 | 28/02/14 |
Todd Garner
DFI | Director of Finance/CFO | 55 | 01/01/18 |
Patrick Beyer
COO | Chief Operating Officer | 58 | 08/12/14 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
David Bronson
BRD | Director/Board Member | 70 | 30/06/15 |
| Director/Board Member | 66 | 25/07/13 | |
John Workman
BRD | Director/Board Member | 62 | 30/06/15 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.19% | 509 M€ | -.--% |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26/04/24 | 65.78 | +6.27% | 1,135,843 |
| 25/04/24 | 61.9 | -11.58% | 2,611,493 |
| 24/04/24 | 70.01 | -1.82% | 1,191,703 |
| 23/04/24 | 71.31 | -1.79% | 532,872 |
| 22/04/24 | 72.61 | -0.04% | 341,874 |
Delayed Quote Nyse, April 26, 2024 at 09:00 pm
More quotes
CONMED Corporation is a medical technology company, which provides surgical devices and equipment for minimally invasive procedures. Its products are used by surgeons and other healthcare professionals in a variety of specialties including orthopedics, general surgery, gynecology, thoracic surgery, and gastroenterology. Its product lines consist of orthopedic surgery and general surgery. Orthopedic surgery consists of sports medicine and lower extremities instrumentation and implants, small bone, large bone, and specialty powered surgical instruments as well as imaging systems for use in minimally invasive surgery procedures and fees related to the sales representation, promotion, and marketing of sports medicine allograft tissue. General surgery consists of endo-mechanical instrumentation for minimally invasive laparoscopic and gastrointestinal procedures, smoke evacuation devices, a line of cardiac monitoring products as well as electrosurgical generators and related instruments.
Calendar
22/05/2024
- Annual General Meeting
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
B-
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
8
Last Close Price
65.78
USD
Average target price
92.38
USD
Spread / Average Target
+40.43%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -39.93% | 2.03B | |
| -2.31% | 187B | |
| -3.20% | 106B | |
| -5.04% | 66.9B | |
| +0.20% | 49.45B | |
| +17.29% | 48B | |
| +4.06% | 40.84B | |
| +2.07% | 26.48B | |
| +2.36% | 26.25B | |
| +12.96% | 24.62B |
- Stock Market
- Equities
- CNMD Stock
